Back to TCRX

CITADEL ADVISORS LLC → TCRX

CITADEL ADVISORS LLC TCRX Position History

TScan Therapeutics, Inc. • Healthcare

Quarters held
7
Latest value
$16K
Q3 2026
Peak value
$963K
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$233K
Q1 2026$88K
Q2 2026$26K
Q2 2026$963K
Q2 2026$26K
Q2 2026$963K
Q3 2026$16K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$16K51.8K——
Q2 2026$963K982.8K——
Q2 2026$26K26.4K——
Q2 2026$963K982.8K——
Q2 2026$26K26.4K——
Q1 2026$88K87.3K——
Q1 2026$233K231.2K——

Other funds holding TCRX

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B